NCT04547257View on ClinicalTrials.gov

Safety & Effectiveness Evaluation of Seraph 100 in Treatment of Pts With COVID-19

NAUnknownINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

May 4, 2021

Primary Completion Date

July 31, 2022

Study Completion Date

December 31, 2022

Conditions
COVID-19
Interventions
DEVICE

Seraph 100

Bloodfiltration with Seraph 100

Trial Locations (5)

12351

ACTIVE_NOT_RECRUITING

Vivantes Klinikum Neukölln, Berlin

28040

ACTIVE_NOT_RECRUITING

Hospital Clinico San Carlos, Madrid

45147

ACTIVE_NOT_RECRUITING

Universitätsklinikum Essen, Essen

63739

RECRUITING

Klinikum Aschaffenburg-Alzenau, Aschaffenburg

08035

RECRUITING

Hospital Universitari Vall d'Hebron, Barcelona

Sponsors
All Listed Sponsors
collaborator

ExThera Medical Corporation

INDUSTRY

collaborator

Vivantes Clinic Neukölln

OTHER

lead

ExThera Medical Europe BV

INDUSTRY

NCT04547257 - Safety & Effectiveness Evaluation of Seraph 100 in Treatment of Pts With COVID-19 | Biotech Hunter | Biotech Hunter